Importantly, several of the pharmacodynamic markers observed in vitro were recapitulated in the in vivo setting e.g., a reduction in tumor cell c-Myc expression accompanied by an increase in DNA damage (e.g., up-regulation of γH2A.X, arguing that similar mechanisms underlying interactions may be operative in the two settings. This evidence concerns the gene MYC and neoplasm.